default author photo

Maxime Frelaut

Gustave Roussy

SCHOLARLY PAPERS

2

DOWNLOADS

130

TOTAL CITATIONS

0

Scholarly Papers (2)

Actions:
Email selected abstracts
1.

Overall Survival Impact of Pembrolizumab Duration and Comorbidities on Advanced NSCLC: A Nationwide Cohort Study

Number of pages: 37 Posted: 05 Mar 2024
Adrien Rousseau, Stefan Michiels, Julian Bonastre, Alexandre Lolivier, David Planchard, Fabrice Barlesi, Jordi Remon, Pernelle Lavaud, Mihaela Aldea, Maxime Frelaut, Cecile Le Pechoux, Angela Botticella, Antonin Levy, Anas Gazzah, Stéphanie Foulon and Benjamin Besse
Gustave Roussy, University of Paris-Saclay, Gustave Roussy, Gustave Roussy, Gustave Roussy, Gustave Roussy, Gustave Roussy, Gustave Roussy, Gustave Roussy, Gustave Roussy, Université Paris XI Sud - Institut Gustave Roussy/Gustave Roussy Villejuif, Gustave Roussy, Gustave Roussy, Gustave Roussy - Drug Development Department (DITEP), Gustave Roussy and Comité de Pathologies Thoraciques
Downloads 95 (725,554)

Abstract:

Loading...

Pembrolizumab, NSCLC, Cohort, Real-life data, IPTW

2.

Feasibility and clinical relevance of the G-CODE in older adults treated in Phase 1 Clinical Trials at Gustave Roussy

Number of pages: 15 Posted: 15 Oct 2025
Capucine Baldini, Lauren Seknazi, Nikolina Gkolemi, Vincent Goldschmidt, Kaïssa Ouali, Madona Sakkal, Cristina Smolenschi, Antoine Hollebecque, Anas Gazzah, Rastio Bahleda, Thomas Hueso, Jean-Marie Michot, Vincent Ribrag, Sophie Postel Vinay, Aurélien Marabelle, Stephane Champiat, Francois-Xavier Danlos, Zoé ap Thomas, Yohann Loriot, Christophe Massard and Maxime Frelaut
Gustave Roussy - Drug Development Department (DITEP), affiliation not provided to SSRN, Gustave Roussy, Gustave Roussy - Drug Development Department (DITEP), Gustave Roussy, Gustave Roussy, Gustave Roussy, Gustave Roussy - Drug Development Department (DITEP), Gustave Roussy - Drug Development Department (DITEP), Gustave Roussy, University of Paris-Saclay - Department of Hematology, Gustave Roussy - Drug Development Department (DITEP), Gustave Roussy - Drug Development Department (DITEP), Gustave Roussy, Gustave Roussy, Gustave Roussy, Gustave Roussy, Gustave Roussy, Université Paris XI Sud - Gustave Roussy Cancer Campus, Gustave Roussy - Drug Development Department (DITEP) and Gustave Roussy
Downloads 35 (1,263,436)

Abstract:

Loading...

G-CODE, geriatric assessment, phase 1 clinical trials, older adults, feasibility, Toxicity